| Evaluation of hydroxyethyl esters of mefenamic acid and diclofenac as prodrugs JA Jilani, GK Pillai, MS Salem, NM Najib Drug development and industrial pharmacy 23 (3), 319-323, 1997 | 24 | 1997 |
| Synthesis and evaluation of mutual azo prodrug of 5-aminosalicylic acid linked to 2-phenylbenzoxazole-2-yl-5-acetic acid in ulcerative colitis JA Jilani, M Shomaf, KH Alzoubi Drug Design, Development and Therapy, 691-698, 2013 | 18 | 2013 |
| Synthesis, In Vitro and In Vivo Evaluation of the N-ethoxycarbonylmorpholine Ester of Diclofenac as a Prodrug JA Jilani, NM Idkaidek, KH Alzoubi Pharmaceuticals 7 (4), 453-463, 2014 | 16 | 2014 |
| Physiologically-based IVIVC of azithromycin NM Idkaidek, N Najib, I Salem, J Jilani Am J Pharmacol Sci 2 (6), 100-2, 2014 | 14 | 2014 |
| Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compounds J Jilani US Patent App. 10/767,581, 2005 | 7 | 2005 |
| Synthesis and In-Vivo Evaluation of Benzoxazole Derivatives as Promising Anti-Psoriatic Drugs for Clinical Use R Ayoub, J Jilani, Q Jarrar, R Alani, C Ardianto, KW Goh, D Ali, ... Molecules 27 (9), 3023, 2022 | 6 | 2022 |
| Bioequivalence study of two capsule formulations of omeprazole. GK Pillai, MS Salem, NM Najib, J Jilani, MM Hasan, E Ghanem, E Sallam, ... Acta Pharmaceutica Hungarica 66 (6), 231-235, 1996 | 5 | 1996 |
| Synthesis and biological evaluation of hydroxypropyl ester of mefenamic acid as a promising prodrug Q Jarrar, R Ayoub, S Moshawih, Y Jarrar, J Jilani Letters in Drug Design & Discovery 20 (2), 144-152, 2023 | 4 | 2023 |
| Regioselective deprotection of the monosaccharide‐bearing thiocyanomethyl group at the anomeric position monitored by reversed‐phase HPLC method Q Abualassal, KM Al Azzam, JA Jilani Biomedical Chromatography 30 (9), 1416-1422, 2016 | 4 | 2016 |
| Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compounds J Jilani US Patent App. 10/059,959, 2003 | 4 | 2003 |
| Synthesis and evaluation of some acyloxyethyl mefenamates as possible prodrugs. JA Jilani, NM Najib, SH Ghariabeh Acta Pharmaceutica Hungarica 67 (2-3), 99-104, 1997 | 4 | 1997 |
| Synthesis, characterization and biological evaluation of some 2-arylbenzoxazole acetic acid derivatives as promising anticancer agents A jilani acta poloniea pharmaceutica-drug research. 77, 717-723, 2020 | 3 | 2020 |
| Evaluation of hydroxyethyldiclofenac intestinal absorption in rats NM Idkaidek, JA Jilani, IA Mansi Saudi Pharmaceutical Journal 13 (4), 158, 2005 | 2 | 2005 |
| The Toxicity and Therapeutic Efficacy of Mefenamic Acid and its Hydroxyethyl Ester in Mice: In Vivo Comparative Study: A promising Drug Derivative I Adel, Q Jarrar, R Ayoub, J Jilani, S Moshawih, E Al-Qadi, M Zihlif Jordan Journal of Pharmaceutical Sciences 15 (4), 507-522, 2022 | 1 | 2022 |
| A one-pot synthesis of 8-amino-1-methoxy-6H-dibenzo[b,d]pyran-6-one JA Jilani Chemical Papers 61, 410-412, 2007 | 1 | 2007 |
| Evaluation ofHydroxyethyldiclofenac as Possible Prodrug for Topical Application J Jilani, A Shatnawi ACTA Pharmaceutica Sciencia 45 (3), 2003 | 1 | 2003 |
| Bioequivalence of two capsule formulations of piroxicam MM Hasan, JA Jilani, MS Salem, NMNA JIB, GK Pillai, E Ganem ACTA Pharmaceutica Sciencia 39 (3), 1997 | 1 | 1997 |
| Synthesis, characterization and biological evaluation of some 2-arylbenzoxazole acetic acid derivatives as potential anticancer agents JA Jilani, QI Abualassal, AM Assaf, RMA Shmies NIScPR-CSIR, India, 2021 | | 2021 |
| Novel compounds for the prophylaxis and treatment of inflammatory bowel diseases J Jilani US Patent App. 11/343,241, 2007 | | 2007 |
| Synthesis and evaluation of penicillin-V prodrug MA HASSAN, M SALIM, AK SHAKYA, J JILANI, K ABU-SHANDI, N NAJIB ACTA Pharmaceutica Sciencia 42 (1), 2000 | | 2000 |
